| Form type | Sec Links | Description | Filing date | Reporting date |
|---|---|---|---|---|
| 8-K | Report | Data | FORM 8-K | Sep 4, 2024 | Aug 28, 2024 |
| 8-K | Report | Data | FORM 8-K | Aug 8, 2024 | Aug 8, 2024 |
| 10-Q | Report | Data | 10-Q | Aug 8, 2024 | Jun 30, 2024 |
| SC 13D/A | Report | AMENDMENT NO. 1 TO THE SCHEDULE 13D | Jul 16, 2024 | |
| 8-K | Report | Data | FORM 8-K | Jul 15, 2024 | Jul 14, 2024 |
| 8-K | Report | Data | FORM 8-K | May 29, 2024 | May 29, 2024 |
| 8-K | Report | Data | FORM 8-K | May 13, 2024 | May 13, 2024 |
| 10-Q | Report | Data | 10-Q | May 13, 2024 | Mar 31, 2024 |
| 10-K/A | Report | Data | FORM 10-K/A | Apr 29, 2024 | Dec 31, 2023 |
| 8-K | Report | Data | FORM 8-K | Apr 8, 2024 | Apr 8, 2024 |
| 8-K | Report | Data | FORM 8-K | Mar 28, 2024 | Mar 28, 2024 |
| 8-K | Report | Data | FORM 8-K | Mar 21, 2024 | Mar 21, 2024 |
| 10-K | Report | Data | 10-K | Mar 21, 2024 | Dec 31, 2023 |
| 8-K | Report | Data | FORM 8-K | Mar 4, 2024 | Feb 28, 2024 |
| 8-K | Report | Data | FORM 8-K | Feb 26, 2024 | Feb 26, 2024 |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2024 | |
| SC 13G/A | Report | MILESTONE PHARMACEUTICALS INC. | Feb 14, 2024 | |
| SC 13G/A | Report | Feb 9, 2024 | ||
| SC 13G/A | Report | Jan 29, 2024 | ||
| SC 13G/A | Report | Jan 24, 2024 | ||
| 8-K | Report | Data | FORM 8-K | Dec 26, 2023 | Dec 26, 2023 |
| 8-K | Report | Data | FORM 8-K | Nov 13, 2023 | Nov 13, 2023 |
| 8-K | Report | Data | FORM 8-K | Nov 13, 2023 | Nov 11, 2023 |
| 10-Q | Report | Data | 10-Q | Nov 13, 2023 | Sep 30, 2023 |
| SC 13D | Report | THE SCHEDULE 13D | Nov 9, 2023 | |
| 8-K | Report | Data | FORM 8-K | Nov 7, 2023 | Nov 7, 2023 |
| 8-K | Report | Data | FORM 8-K | Oct 24, 2023 | Oct 24, 2023 |
| 8-K | Report | Data | FORM 8-K | Aug 10, 2023 | Aug 10, 2023 |
| 10-Q | Report | Data | 10-Q | Aug 10, 2023 | Jun 30, 2023 |
| 8-K | Report | Data | FORM 8-K | Jun 9, 2023 | Jun 7, 2023 |
| 10-K/A | Report | Data | 10-K/A | May 31, 2023 | Dec 31, 2022 |
| 8-K | Report | Data | FORM 8-K | May 11, 2023 | May 11, 2023 |
| 10-Q | Report | Data | 10-Q | May 11, 2023 | Mar 31, 2023 |
| 8-K | Report | Data | FORM 8-K | Mar 31, 2023 | Mar 27, 2023 |
| 8-K | Report | Data | FORM 8-K | Mar 29, 2023 | Mar 29, 2023 |
| 10-K | Report | Data | 10-K | Mar 29, 2023 | Dec 31, 2022 |
| 8-K | Report | Data | FORM 8-K | Mar 28, 2023 | Mar 27, 2023 |
| 8-K | Report | Data | FORM 8-K | Mar 27, 2023 | Mar 21, 2023 |
| 8-K | Report | Data | FORM 8-K | Mar 10, 2023 | Mar 10, 2023 |
| 8-K | Report | Data | FORM 8-K | Mar 7, 2023 | Mar 7, 2023 |
| SC 13G/A | Report | AMENDMENT NO. 1 | Feb 14, 2023 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2023 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2023 | |
| SC 13G/A | Report | Feb 14, 2023 | ||
| SC 13G/A | Report | SC 13G/A | Feb 14, 2023 | |
| SC 13G/A | Report | Feb 13, 2023 | ||
| SC 13G | Report | Jan 19, 2023 | ||
| SC 13G/A | Report | Jan 18, 2023 | ||
| 8-K | Report | Data | FORM 8-K | Dec 6, 2022 | Dec 6, 2022 |
| 8-K | Report | Data | FORM 8-K | Nov 10, 2022 | Nov 10, 2022 |
| 10-Q | Report | Data | 10-Q | Nov 10, 2022 | Sep 30, 2022 |
| SC 13G | Report | Oct 31, 2022 | ||
| SC 13D/A | Report | SC 13D/A | Oct 24, 2022 | |
| 8-K | Report | Data | FORM 8-K | Oct 17, 2022 | Oct 17, 2022 |
| SC 13D/A | Report | SC 13D/A | Sep 26, 2022 | |
| SC 13G | Report | SC 13G | Sep 20, 2022 | |
| 8-K | Report | Data | FORM 8-K | Aug 10, 2022 | Aug 10, 2022 |
| 10-Q | Report | Data | 10-Q | Aug 10, 2022 | Jun 30, 2022 |
| 8-K | Report | Data | FORM 8-K | Jul 8, 2022 | Jul 8, 2022 |
| 10-Q | Report | Data | 10-Q | May 12, 2022 | Mar 31, 2022 |
| 8-K | Report | Data | FORM 8-K | Mar 24, 2022 | Mar 24, 2022 |
| 10-K | Report | Data | 10-K | Mar 24, 2022 | Dec 31, 2021 |
| 8-K | Report | Data | FORM 8-K | Feb 16, 2022 | Feb 15, 2022 |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2022 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2022 | |
| SC 13G/A | Report | SC 13G/A | Feb 14, 2022 | |
| SC 13G/A | Report | Feb 14, 2022 | ||
| SC 13G/A | Report | AMENDMENT NO. 1 | Feb 11, 2022 | |
| 8-K | Report | Data | FORM 8-K | Nov 12, 2021 | Nov 12, 2021 |
| 10-Q | Report | Data | 10-Q | Nov 12, 2021 | Sep 30, 2021 |
| 10-Q | Report | Data | 10-Q | Aug 11, 2021 | Jun 30, 2021 |
| 8-K | Report | FORM 8-K | Jun 21, 2021 | Jun 14, 2021 |
| 8-K | Report | FORM 8-K | Jun 2, 2021 | Jun 2, 2021 |
| 8-K | Report | FORM 8-K | May 17, 2021 | May 15, 2021 |
| 10-Q | Report | Data | 10-Q | May 17, 2021 | Mar 31, 2021 |
| 8-K | Report | FORM 8-K | Mar 30, 2021 | Mar 29, 2021 |
| 10-K | Report | Data | 10-K | Mar 29, 2021 | Dec 31, 2020 |
| SC 13G/A | Report | SC 13G/A | Feb 16, 2021 | |
| SC 13G | Report | SCHEDULE 13G | Feb 16, 2021 | |
| SC 13G/A | Report | Feb 16, 2021 | ||
| SC 13G/A | Report | SC 13G/A | Feb 16, 2021 | |
| SC 13G | Report | SCHEDULE 13G | Feb 12, 2021 | |
| SC 13G/A | Report | Feb 12, 2021 | ||
| SC 13G/A | Report | AMENDMENT NO. 1 | Feb 12, 2021 | |
| SC 13G/A | Report | SCHEDULE 13G/A FOR MILESTONE PHARMACEUTICALS INC. ON BEHALF OF DOMAIN PARTNERS V | Jan 21, 2021 | |
| SC 13G | Report | SC 13G | Jan 11, 2021 | |
| 10-Q | Report | Data | 10-Q | Nov 13, 2020 | Sep 30, 2020 |
| 8-K | Report | FORM 8-K | Oct 26, 2020 | Oct 22, 2020 |
| 10-K/A | Report | Data | 10-K/A | Oct 23, 2020 | Dec 31, 2019 |
| 8-K | Report | FORM 8-K | Sep 22, 2020 | Sep 21, 2020 |
| 10-Q | Report | Data | 10-Q | Aug 12, 2020 | Jun 30, 2020 |
| SC 13G | Report | SC 13G | Aug 3, 2020 | |
| 8-K | Report | FORM 8-K | Jul 29, 2020 | Jul 29, 2020 |
| 8-K | Report | FORM 8-K | Jul 23, 2020 | Jul 22, 2020 |
| 8-K | Report | FORM 8-K | Jun 9, 2020 | Jun 4, 2020 |
| 10-Q | Report | Data | 10-Q | May 14, 2020 | Mar 31, 2020 |
| SC 13G/A | Report | SCHEDULE 13G/A | Apr 3, 2020 | |
| 8-K | Report | FORM 8-K | Mar 23, 2020 | Mar 23, 2020 |
| SC 13D/A | Report | AMENDMENT NO. 3 TO SCHEDULE 13D | Mar 12, 2020 | |
| 10-K | Report | Data | 10-K | Mar 6, 2020 | Dec 31, 2019 |
| SC 13G | Report | SCHEDULE 13G | Feb 14, 2020 | |
| SC 13G/A | Report | Feb 14, 2020 | ||
| SC 13G | Report | Feb 14, 2020 | ||
| SC 13G | Report | SC 13G | Feb 11, 2020 | |
| SC 13G | Report | SCHEDULE 13G FOR MILESTONE PHARMACEUTICALS INC. BY DOMAIN PARTNERS VIII, L.P. | Jan 9, 2020 | |
| 8-K | Report | FORM 8-K | Dec 17, 2019 | Dec 17, 2019 |
| 8-K | Report | FORM 8-K | Dec 3, 2019 | Nov 29, 2019 |
| SC 13D/A | Report | AMENDMENT NO. 2 TO SCHEDULE 13D | Nov 27, 2019 | |
| 10-Q | Report | Data | 10-Q | Nov 13, 2019 | Sep 30, 2019 |
| 8-K | Report | 8-K | Nov 13, 2019 | Nov 11, 2019 |
| 8-K | Report | 8-K | Oct 15, 2019 | Oct 8, 2019 |
| SC 13D/A | Report | AMENDMENT NO. 1 TO SCHEDULE 13D | Sep 20, 2019 | |
| 8-K | Report | 8-K | Sep 20, 2019 | Sep 18, 2019 |
| 8-K | Report | 8-K | Sep 10, 2019 | Sep 9, 2019 |
| 10-Q | Report | Data | 10-Q | Aug 13, 2019 | Jun 30, 2019 |
| 8-K | Report | 8-K | Aug 13, 2019 | Aug 13, 2019 |
| 10-Q | Report | Data | 10-Q | Jun 19, 2019 | Mar 31, 2019 |
| 8-K | Report | 8-K | May 24, 2019 | May 24, 2019 |
| SC 13G | Report | May 20, 2019 | ||
| 8-K | Report | 8-K | May 15, 2019 | May 13, 2019 |
| SC 13G | Report | SCHEDULE 13G | May 15, 2019 | |
| SC 13D | Report | SC 13D | May 14, 2019 |